Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Company News

As of July 12, 2025 • 7:00 AM ET

Date/Time Source News Release
06/26/2025 08:03 AM EDT PR Newswire HOPE Therapeutics, Inc. and NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Announce Agreement to Acquire Interest in Cohen and Associates, LLC for HOPE's Network of Interventional Psychiatry Clinics
06/24/2025 08:30 AM EDT GlobeNewswire IBN Initiates Coverage of NRx Pharmaceuticals Inc.
06/16/2025 08:03 AM EDT PR Newswire NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) and HOPE Therapeutics, Inc. Announce Strategic Investor Relations Partnership with astr partners
06/12/2025 08:03 AM EDT PR Newswire NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) and HOPE Therapeutics, Inc. to Present at H.C. Wainwright 6th Annual Neuro Perspectives Hybrid Conference
06/05/2025 08:03 AM EDT PR Newswire NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Files Abbreviated New Drug Application (ANDA) for Preservative-Free IV Ketamine
05/21/2025 08:03 AM EDT PR Newswire NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) and HOPE Therapeutics(TM), Inc. Selected to Present at the Wall Street Conference on May 21, 2025, in Palm Beach, Florida
05/15/2025 04:03 PM EDT PR Newswire NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Reports First Quarter 2025 Financial Results and Provides Corporate Update
05/15/2025 10:15 AM EDT PR Newswire HOPE Therapeutics, Inc. a subsidiary of NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Announces Signing of Term Sheet for $7.8 Million Debt Financing to Fuel HOPE Clinic Acquisitions
05/13/2025 08:03 AM EDT PR Newswire HOPE Therapeutics, Inc. and NRx Pharmaceuticals (NASDAQ:NRXP) Announce Signing of Definitive Agreement to Purchase Kadima Neuropsychiatry Institute; Foundational Acquisition for the HOPE Network of Interventional Psychiatry Clinics
05/12/2025 08:03 AM EDT PR Newswire NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) to Report First Quarter 2025 Financial Results on May 15, 2025
Page

Additional News

As of July 12, 2025 • 7:00 AM ET

Date/Time Source News Release
07/08/2025 09:05 AM EDT BioMedWire NRx Pharmaceuticals Inc. (NASDAQ: NRXP) Subsidiary to Acquire 49% Stake in Prominent Florida Neuropsychiatry Clinic
06/27/2025 09:50 AM EDT PsychedelicNewsWire NRx Pharmaceuticals Inc. (NASDAQ: NRXP) Applies for FDA Commissioner's National Priority Voucher for IV Ketamine NRX-100
06/26/2025 09:57 AM EDT BioMedWire BioMedNewsBreaks - NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) Subsidiary HOPE Therapeutics to Acquire 49% Stake in Leading Florida Psychiatry Clinic
06/24/2025 09:15 AM EDT PsychedelicNewsWire PsychedelicNewsBreaks - NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) Taps IBN to Lead Corporate Communications Amid Drug Advancements and Subsidiary Launch
06/23/2025 09:25 AM EDT BioMedWire BioMedNewsBreaks - NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) Applies for FDA Commissioner's Priority Voucher for NRX-100 Ketamine Formulation
06/20/2025 04:52 PM EDT SeekingAlpha NRx Pharmaceuticals files $150M mixed shelf offering
06/16/2025 09:25 AM EDT BioMedWire BioMedNewsBreaks - NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) Forms Investor Relations Partnership With astr Partners
06/12/2025 09:15 AM EDT BioMedWire BioMedNewsBreaks - NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) and HOPE Therapeutics to Present at H.C. Wainwright Neuro Perspectives Conference
06/12/2025 09:05 AM EDT PsychedelicNewsWire NRx Pharmaceuticals Inc. (NASDAQ: NRXP) Files Abbreviated New Drug Application for Preservative-Free IV Ketamine NRX-100 Amid Ongoing Shortage
06/05/2025 11:20 AM EDT PsychedelicNewsWire NRx Pharmaceuticals Inc. (NASDAQ: NRXP) Signs Agreement to Acquire Kadima to Launch $100M Psychiatry Clinic Network
Page